-
Product Insights
NewGraft Versus Host Disease (GVHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Graft Versus Host Disease Clinical Trials Market Report Overview The Graft Versus Host Disease clinical trial market research report provides an overview of the Graft Versus Host Disease clinical trials scenario. The report provides top-line data relating to the clinical trials on Graft Versus Host Disease. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Thematic Analysis
Digital Marketing Trends in Rheumatoid Arthritis
Digital Marketing Trends in Rheumatoid Arthritis Report Overview AbbVie’s Rinvoq.com achieved the highest total traffic across rheumatoid arthritis (RA) patient brand sites in the US, with over four million visitors from February 2022 to January 2023. This was followed by AbbVie’s Humira.com and Amgen’s Enbrel.com. The highest proportion of traffic to branded patient RA websites originated from organic sources, followed by direct. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Amgen spent the most on digital display advertising (DDA)...
-
Sector Analysis
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031
Systemic Lupus Erythematosus and Lupus Nephritis Market Report Overview The diagnosed incident cases of Systemic Lupus Erythematosus (SLE) were 36,601 in the seven major markets (7MM) in 2021 and are expected to achieve an AGR of less than 1%. Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a chronic relapsing and remitting course, having variable manifestations ranging from mild to life-threatening illness (Tsokos, 2011). In SLE, the immune system attacks its own tissues, causing widespread inflammation and tissue...
-
Product Insights
Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Lupus Nephritis Clinical Trials Market Report Overview The Lupus Nephritis Clinical Trial provides an overview of Lupus Nephritis Clinical trials scenario. The report provides top line data relating to the clinical trials on Lupus Nephritis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
-
Product Insights
Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Psoriasis Clinical Trials Market Overview The psoriasis clinical trial market research report provides an overview of the psoriasis clinical trials scenario. The report provides top-line data relating to the clinical trials on psoriasis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hereditary Angioedema Clinical Trials Market Report Overview The hereditary angioedema (HAE) clinical trial market research report provides an overview of the hereditary angioedema clinical trials scenario. The report provides top-line data relating to the clinical trials on hereditary angioedema. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor...
-
Thematic Analysis
Digital Marketing Trends in Psoriasis
Digital Marketing Trends in Psoriasis Report Overview AbbVie's Skyrizi.com achieved the highest total traffic across branded PsO patient sites in the US with almost 7.2 million visitors between January 2022-December 2022. This was followed by Novartis's Cosentyx.com (3.3 million visits) and AbbVie's Humira.com (2.3 million visits). Amgen spent the most on digital display advertising (DDA) for Otezla.com, followed by Enbrel.com. Cosentyx.com was supported by the most paid search engine optimization, followed by Otezla.com and Stelarainfo.com. The digital marketing trends in...
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hereditary Angioedema (HAE) is a rare inherited disease that causes considerable swelling in various body tissues, such as the abdomen or face. Symptoms include severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing and difficulty breathing. Treatment includes medications, such as epinephrine, antihistamines, and corticosteroids. The Hereditary Angioedema pipeline drugs market research report provides comprehensive information on the therapeutics under development for Hereditary Angioedema, complete with analysis by stage of development, drug target, mechanism of action...
-
Product Insights
Sicca Syndrome (Sjogren) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Sicca Syndrome or Sjogren's syndrome is an autoimmune disease. It involves inflammation of glands and other tissues of the body. Symptoms include skin rashes or dry skin, vaginal dryness, persistent dry cough, prolonged fatigue, dry eye, dry mouth, joint pain, swelling, and stiffness. Predisposing factors include age, sex, and rheumatic disease. The Sicca Syndrome pipeline drugs market research report provides comprehensive information on the therapeutics under development for Sicca Syndrome, complete with analysis by stage of development, drug target, mechanism...
-
Product Insights
Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Heart transplantation is the therapy used in various heart diseases. Heart transplant replaces an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted heart as foreign and may work against it. Patients may hence develop complications and eventually reject the new organ. Immunosuppressive drugs are administered simultaneously which prevent the body from either identifying or attacking the foreign organ...
-
Product Insights
Digital Health Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
The digital health in immunology market size was valued at US$6.07 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027. Digital health has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine. Digital health applications in immunology have gained significant momentum owing to the following factors: Enhanced access to healthcare Affordable cost of healthcare Improve the quality of care Reduce any...
-
Product Insights
Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The systemic lupus erythematosus clinical trial market research report provides an overview of the systemic lupus erythematosus clinical trials scenario. The report provides top-line data relating to the clinical trials on systemic lupus erythematosus. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Systemic Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The inflammation triggered by Systemic Lupus Erythematosus (SLE) affects many organs in the body, including skin, joints, kidneys, brain, and other organs. Several factors have been associated with the disease such as genetics, environment and gender, and hormones. The Systemic Lupus Erythematosus pipeline market research report provides comprehensive information on the therapeutics under development for Systemic Lupus Erythematosus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report...
-
Product Insights
Pemphigus Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on the skin and the mucous membranes. Risk factors include race, gender and age. Symptoms of pemphigus vulgaris include painful blisters that start in the mouth, skin blisters that come and go; the blisters always occur near the surface of the skin and oozing, crusting, or peeling at the blister site. The Pemphigus Vulgaris pipeline drugs market research report provides a comprehensive information on the therapeutics under development for...
-
Product Insights
Anaphylaxis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma and family history. Treatment includes beta-agonist, antihistamines and cortisone. The Anaphylaxis pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route...
-
Product Insights
Lung Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Lung transplantation is the therapy used in various lung diseases. Lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. Patients may hence develop complications and eventually reject the new organ. Immunosuppressive drugs are administered simultaneously which prevent the body from either identifying or attacking the foreign organ...
-
Product Insights
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Systemic Sclerosis (Scleroderma) clinical trial market research report provides an overview of the Systemic Sclerosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Systemic Sclerosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Myasthenia Gravis (MG) is a relatively rare, acquired, chronic, autoimmune neuromuscular disease caused by an antibody-mediated blockade at the neuromuscular transmission, resulting in skeletal muscle weakness and rapid muscle fatigue. In many adults with MG, the thymus gland remains large. People with the disease typically have clusters of immune cells in their thymus gland and may develop thymomas (tumors of the thymus gland). The myasthenia gravis marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, pricing...
-
Product Insights
Peanut Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy – Drugs In Development, 2022, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such...
-
Sector Analysis
Sjogrens Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Sjögren’s Syndrome (SS) is a chronic and systemic autoimmune inflammatory disorder in which an initial immunological attack that primarily targets the lacrimal and salivary glands and results in keratoconjunctivitis sicca (KCS [dry eye disease]) and/or stomatitis sicca (dry mouth disease). Though sometimes referred to as “sicca syndrome,” referring to dryness of the exocrine glands, symptoms that most SS patients do display, a patient is only classified as having sicca when there is no evidence of the presence of an autoimmune...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.